What is a drug patent link? First of all, we must understand this concept. In fact, drug approval is linked to patents, because drug approval is the responsibility of the Food and Drug Administration, and patent disputes involve intellectual property offices and intellectual property courts. So, what is the purpose of connecting them? That is to say, in the process of drug approval, if patent infringement disputes are found, they can be resolved by court ruling. Resolving patent disputes and infringement risks before the drug goes on the market is conducive to protecting the legitimate rights and interests of patentees, improving patent quality and reducing the market risk of generic drug companies challenging patents.
What is patent period compensation? It takes up the patentee's time in the process of administrative examination and approval. The longer the examination and approval time, the longer the patent protection time, which damages the rights and interests of the patentee. To this end, the regulatory authorities give certain reasonable compensation for the patent time occupied.
The so-called data protection means that the data obtained by researchers themselves will not be used by others, and the administrative department should take protective measures for the data declared by enterprises.
This series of measures for the protection of pharmaceutical intellectual property rights fully meet the needs of building an innovative country and promoting the innovation and development of pharmaceutical industry in China, and will play a great role in protecting and encouraging the vigorous development of national pharmaceutical innovation in China, especially in the field of traditional Chinese medicine with independent intellectual property rights, and will comprehensively enhance the innovation and development level of China's pharmaceutical industry.